Effects of paraventricular nucleus injection of CCK-8 on plasma CCK-8 levels in rats

J. Ernie Blevins, Frederick G. Hamel, Elizabeth Fairbairn, B. Glenn Stanley, Roger D. Reidelberger

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The aim of the study was to determine whether paraventricular nucleus (PVN) injection of an anorexic 500-pmol dose of cholecystokinin (CCK)-8 could increase plasma CCK-8 levels sufficiently to suppress feeding by a peripheral mechanism. Rats received PVN injections of CCK-8 either alone or with 3H- labelled propionylated CCK-8 (3H-pCCK-8) and plasma samples were taken at various times from 3 to 120 min post-injection. Plasma CCK-8 levels were estimated from measurements of both total plasma CCK-like immunoreactivity (CCK-LI) and 3H-pCCK-8 activity. PVN injections of CCK-8 and 3H-pCCK-8 produced estimated peak increases in plasma CCK-8 of 15 ± 11 and 22 ± 3 pM, respectively. The i.v. infusion of CCK-8 doses (0.2 and 1 nmol/kg h) that bracketed the threshold dose for suppression of feeding, increased plasma CCK-LI from a basal level of 6 ± 1 to 49 ± 10 and 166 ± 36 pM, respectively. The i.v. injections of 600 and 4800 pmol of CCK-8 did not suppress feeding. These results suggest that PVN injection of an anorexic 500-pmol dose of CCK-8 does not increase plasma CCK-8 levels sufficiently to suppress feeding by a peripheral mechanism. (C) 2000 Elsevier Science B.V.

Original languageEnglish (US)
Pages (from-to)11-20
Number of pages10
JournalBrain Research
Volume860
Issue number1-2
DOIs
StatePublished - Mar 31 2000

Fingerprint

Paraventricular Hypothalamic Nucleus
Injections
Cholecystokinin
Sincalide
cholecystokinin 8

Keywords

  • Appetite regulation
  • Brain
  • Neuropeptide
  • Satiety

ASJC Scopus subject areas

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

Effects of paraventricular nucleus injection of CCK-8 on plasma CCK-8 levels in rats. / Blevins, J. Ernie; Hamel, Frederick G.; Fairbairn, Elizabeth; Stanley, B. Glenn; Reidelberger, Roger D.

In: Brain Research, Vol. 860, No. 1-2, 31.03.2000, p. 11-20.

Research output: Contribution to journalArticle

Blevins, J. Ernie ; Hamel, Frederick G. ; Fairbairn, Elizabeth ; Stanley, B. Glenn ; Reidelberger, Roger D. / Effects of paraventricular nucleus injection of CCK-8 on plasma CCK-8 levels in rats. In: Brain Research. 2000 ; Vol. 860, No. 1-2. pp. 11-20.
@article{d9236ac0ddc842c7ad6424c980bdd2f7,
title = "Effects of paraventricular nucleus injection of CCK-8 on plasma CCK-8 levels in rats",
abstract = "The aim of the study was to determine whether paraventricular nucleus (PVN) injection of an anorexic 500-pmol dose of cholecystokinin (CCK)-8 could increase plasma CCK-8 levels sufficiently to suppress feeding by a peripheral mechanism. Rats received PVN injections of CCK-8 either alone or with 3H- labelled propionylated CCK-8 (3H-pCCK-8) and plasma samples were taken at various times from 3 to 120 min post-injection. Plasma CCK-8 levels were estimated from measurements of both total plasma CCK-like immunoreactivity (CCK-LI) and 3H-pCCK-8 activity. PVN injections of CCK-8 and 3H-pCCK-8 produced estimated peak increases in plasma CCK-8 of 15 ± 11 and 22 ± 3 pM, respectively. The i.v. infusion of CCK-8 doses (0.2 and 1 nmol/kg h) that bracketed the threshold dose for suppression of feeding, increased plasma CCK-LI from a basal level of 6 ± 1 to 49 ± 10 and 166 ± 36 pM, respectively. The i.v. injections of 600 and 4800 pmol of CCK-8 did not suppress feeding. These results suggest that PVN injection of an anorexic 500-pmol dose of CCK-8 does not increase plasma CCK-8 levels sufficiently to suppress feeding by a peripheral mechanism. (C) 2000 Elsevier Science B.V.",
keywords = "Appetite regulation, Brain, Neuropeptide, Satiety",
author = "Blevins, {J. Ernie} and Hamel, {Frederick G.} and Elizabeth Fairbairn and Stanley, {B. Glenn} and Reidelberger, {Roger D.}",
year = "2000",
month = "3",
day = "31",
doi = "10.1016/S0006-8993(99)02478-6",
language = "English (US)",
volume = "860",
pages = "11--20",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Effects of paraventricular nucleus injection of CCK-8 on plasma CCK-8 levels in rats

AU - Blevins, J. Ernie

AU - Hamel, Frederick G.

AU - Fairbairn, Elizabeth

AU - Stanley, B. Glenn

AU - Reidelberger, Roger D.

PY - 2000/3/31

Y1 - 2000/3/31

N2 - The aim of the study was to determine whether paraventricular nucleus (PVN) injection of an anorexic 500-pmol dose of cholecystokinin (CCK)-8 could increase plasma CCK-8 levels sufficiently to suppress feeding by a peripheral mechanism. Rats received PVN injections of CCK-8 either alone or with 3H- labelled propionylated CCK-8 (3H-pCCK-8) and plasma samples were taken at various times from 3 to 120 min post-injection. Plasma CCK-8 levels were estimated from measurements of both total plasma CCK-like immunoreactivity (CCK-LI) and 3H-pCCK-8 activity. PVN injections of CCK-8 and 3H-pCCK-8 produced estimated peak increases in plasma CCK-8 of 15 ± 11 and 22 ± 3 pM, respectively. The i.v. infusion of CCK-8 doses (0.2 and 1 nmol/kg h) that bracketed the threshold dose for suppression of feeding, increased plasma CCK-LI from a basal level of 6 ± 1 to 49 ± 10 and 166 ± 36 pM, respectively. The i.v. injections of 600 and 4800 pmol of CCK-8 did not suppress feeding. These results suggest that PVN injection of an anorexic 500-pmol dose of CCK-8 does not increase plasma CCK-8 levels sufficiently to suppress feeding by a peripheral mechanism. (C) 2000 Elsevier Science B.V.

AB - The aim of the study was to determine whether paraventricular nucleus (PVN) injection of an anorexic 500-pmol dose of cholecystokinin (CCK)-8 could increase plasma CCK-8 levels sufficiently to suppress feeding by a peripheral mechanism. Rats received PVN injections of CCK-8 either alone or with 3H- labelled propionylated CCK-8 (3H-pCCK-8) and plasma samples were taken at various times from 3 to 120 min post-injection. Plasma CCK-8 levels were estimated from measurements of both total plasma CCK-like immunoreactivity (CCK-LI) and 3H-pCCK-8 activity. PVN injections of CCK-8 and 3H-pCCK-8 produced estimated peak increases in plasma CCK-8 of 15 ± 11 and 22 ± 3 pM, respectively. The i.v. infusion of CCK-8 doses (0.2 and 1 nmol/kg h) that bracketed the threshold dose for suppression of feeding, increased plasma CCK-LI from a basal level of 6 ± 1 to 49 ± 10 and 166 ± 36 pM, respectively. The i.v. injections of 600 and 4800 pmol of CCK-8 did not suppress feeding. These results suggest that PVN injection of an anorexic 500-pmol dose of CCK-8 does not increase plasma CCK-8 levels sufficiently to suppress feeding by a peripheral mechanism. (C) 2000 Elsevier Science B.V.

KW - Appetite regulation

KW - Brain

KW - Neuropeptide

KW - Satiety

UR - http://www.scopus.com/inward/record.url?scp=0034737378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034737378&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(99)02478-6

DO - 10.1016/S0006-8993(99)02478-6

M3 - Article

C2 - 10727619

AN - SCOPUS:0034737378

VL - 860

SP - 11

EP - 20

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -